Cannabis innovation leads to cannabis capsules for better health

150 0

Consumers who want the benefits of marijuana without inhaling have plenty of options

CBD capsules are becoming a trend within the cannabis community. These capsules can contain many forms of cannabis, such as extracted oil, decarboxylated flower or individual cannabinoids, such as THC (tetrahydrocannabinol) or CBD (cannabidiol). Science has made this type of product possible. In fact, Zelira has designed an innovative technology to make consistent cannabinoid-based oral medications a reality.

Cannabis capsules offer a simple, precisely dosed and subtle way to consume cannabis with long-lasting effects. This has led to many marijuana accessory manufacturers using artificial intelligence (AI) to distribute and weigh flowers more accurately. Growers are using novel and increasingly sustainable technologies to achieve larger and more consistent yields.

Zelira Therapeutics, a global leader in research, development and commercialization of clinically validated cannabinoid medicines, has developed a new cannabinoid delivery vehicle. Its latest breakthrough is reflected in Zyraydi, a patented Enhanced Distillate Dissolution and Capture Matrix (EDCDM) technology. This tool is capable of substantially trapping distillate in a free-flowing powder matrix and increases the dissolution rate.

“I think what we have with cannabinoids and cannabinoid-based pharmacology is that it gives us access to a natural compound with the longest documented history of safety and efficacy among natural compounds at any time,” said Zelira CEO Oludare Odumosu. “With that, we already have half a drug.”

According to the expert, the world of medical marijuana will only evolve or be taken seriously when solid oral dosage forms that the pharmaceutical industry recognizes can be manufactured, a format that patients and prescribers recognize. That is where capsules have been coming into play, furthering the health of the human being who consumes them.